Margaret Barreto

Cooley advised MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and delivery devices for patients with endocrine and orphan lung diseases, on an up to $500 million strategic financing agreement with funds managed by Blackstone.

Cooley advised Xometry, the global artificial intelligence-powered marketplace connecting buyers with suppliers of manufacturing services, on its $250 million aggregate principal amount of 0.75% convertible senior notes due 2030, which includes the initial purchasers’ option to purchase up to an additional $25 million aggregate principal amount of notes.

Cooley advised Conquer, a portfolio company of Camden Partners and Evergreen Mountain Equity Partners and a top Salesforce-native sales engagement platform, on its acquisition of Full Circle Insights, a pioneer in marketing attribution, funnel analytics and account-based marketing.

Cooley advised Oberland Capital, a private investment firm committed to funding innovation across the global healthcare industry, on its agreement to invest up to $600 million in Biohaven (NYSE: BHVN), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases.

Cooley advised NETSTREIT on $275.0 million in additional financing commitments and amendments to its existing credit facilities, agented by PNC Bank, National Association; Wells Fargo Bank, National Association; and Truist Bank. NETSTREIT is a Dallas-based real estate investment trust that acquires single-tenant net lease retail properties across the US. Partner Addison Pierce led the Cooley team advising NETSTREIT, which included partners Christina Roupas and Todd Gluth and associates Margaret Barreto and Cam Irwin.